Home › Juvenile Arthritis › District of Columbia
Juvenile Arthritis clinical trials in District of Columbia
4 studies for Juvenile Arthritis are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Childrens National Medical Center /ID# 253344, Washington D.C.
RecruitingPhase 3
Ages 1 to 17 · All sexes · Updated Sep 15, 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Childrens National Medical Center /ID# 259284, Washington D.C.
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Childrens National Medical Center, Washington D.C.
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
RecruitingObservational study
Ages 5 to 21 · All sexes · Updated Jul 24, 2026 · NCT04833465From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.